[go: up one dir, main page]

RU94042230A - Производные 1,3,4-оксадиазол-2-(3н)-она, их приготовление и применение в терапии - Google Patents

Производные 1,3,4-оксадиазол-2-(3н)-она, их приготовление и применение в терапии

Info

Publication number
RU94042230A
RU94042230A RU94042230/04A RU94042230A RU94042230A RU 94042230 A RU94042230 A RU 94042230A RU 94042230/04 A RU94042230/04 A RU 94042230/04A RU 94042230 A RU94042230 A RU 94042230A RU 94042230 A RU94042230 A RU 94042230A
Authority
RU
Russia
Prior art keywords
group
alkoxy
alkyl
derivatives
ris
Prior art date
Application number
RU94042230/04A
Other languages
English (en)
Inventor
Жан-Жак Кениг
Fr]
Самир Егам
Фредерик Пюэ
Филипп Бюрнье
Original Assignee
Синтелябо (FR)
Синтелябо
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Синтелябо (FR), Синтелябо filed Critical Синтелябо (FR)
Publication of RU94042230A publication Critical patent/RU94042230A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Изобретение касается производных 1,3,4-оксадиазол-2(3Н)-она, соответствующих общей формуле, приведенной в описании, находящихся в форме чистых энантиомеров или смеси энантиомеров, включая рацемические смеси, а также их солей, образующихся в результате добавления фармацевтически приемлемых кислот. Терапевтическое применение.

Claims (1)

  1. Изобретение касается производных 1,3,4-оксадиазол-2(3Н)-она, соответствующих общей формуле, приведенной в описании, находящихся в форме чистых энантиомеров или смеси энантиомеров, включая рацемические смеси, а также их солей, образующихся в результате добавления фармацевтически приемлемых кислот. Терапевтическое применение.
RU94042230/04A 1993-11-26 1994-11-25 Производные 1,3,4-оксадиазол-2-(3н)-она, их приготовление и применение в терапии RU94042230A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9314151 1993-11-26
FR9314151A FR2712886B1 (fr) 1993-11-26 1993-11-26 Dérivés de 1,3,4-oxadiazol-2(3H)-one, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
RU94042230A true RU94042230A (ru) 1996-11-20

Family

ID=9453245

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94042230/04A RU94042230A (ru) 1993-11-26 1994-11-25 Производные 1,3,4-оксадиазол-2-(3н)-она, их приготовление и применение в терапии

Country Status (24)

Country Link
US (1) US5525619A (ru)
EP (1) EP0655445B1 (ru)
JP (1) JPH07196636A (ru)
KR (1) KR950014088A (ru)
CN (1) CN1106395A (ru)
AT (1) ATE157356T1 (ru)
AU (1) AU679127B2 (ru)
CA (1) CA2136669A1 (ru)
CZ (1) CZ291794A3 (ru)
DE (1) DE69405198T2 (ru)
DK (1) DK0655445T3 (ru)
ES (1) ES2107157T3 (ru)
FI (1) FI945562L (ru)
FR (1) FR2712886B1 (ru)
GR (1) GR3025272T3 (ru)
HU (1) HUT71111A (ru)
IL (1) IL111769A (ru)
NO (1) NO944513L (ru)
NZ (1) NZ264991A (ru)
PL (1) PL305999A1 (ru)
RU (1) RU94042230A (ru)
SK (1) SK143594A3 (ru)
TW (1) TW284761B (ru)
ZA (1) ZA949394B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763068B1 (fr) * 1997-05-06 1999-06-04 Synthelabo Derives de 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
FR2766485B1 (fr) * 1997-07-23 2002-05-24 Synthelabo Derives de 2,4-dihydro-3h-1,2,4-triazol-3-one, leur prparation et leur application en therapeutique
JP2001039954A (ja) * 1999-05-24 2001-02-13 Tomono Agrica Co Ltd ヘテロ環誘導体
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
CN104016938B (zh) * 2014-05-28 2016-08-17 浙江工业大学 一种含苯硒基的噁二唑类化合物及其制备与应用
CN104016939B (zh) * 2014-05-28 2016-06-15 浙江工业大学 一种2-亚乙基-3-乙酰基-1,3,4-噁二唑类化合物及其制备与应用
GB201814151D0 (en) 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631827B1 (fr) * 1988-05-27 1992-03-27 Delalande Sa Nouveaux derives d'(hetero)aryl-5 tetrazole, leur procede de preparation et leur application en therapeutique
JPH0366056A (ja) * 1989-08-03 1991-03-20 Matsushita Electric Ind Co Ltd 回転ヘッド装置
FR2655044B1 (fr) * 1989-11-24 1995-03-03 Delalande Sa Derives d'(hetero) arylmethyloxy-4 phenyl tetrazole et oxadiazole, leur procede de preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
HU9403393D0 (en) 1995-02-28
ZA949394B (en) 1995-09-07
IL111769A0 (en) 1995-01-24
FR2712886A1 (fr) 1995-06-02
US5525619A (en) 1996-06-11
CZ291794A3 (en) 1995-07-12
SK143594A3 (en) 1995-06-07
FR2712886B1 (fr) 1996-01-05
NO944513L (no) 1995-05-29
TW284761B (ru) 1996-09-01
FI945562L (fi) 1995-05-27
DE69405198D1 (de) 1997-10-02
NZ264991A (en) 1995-07-26
CN1106395A (zh) 1995-08-09
JPH07196636A (ja) 1995-08-01
ATE157356T1 (de) 1997-09-15
HUT71111A (en) 1995-11-28
AU7903094A (en) 1995-06-01
NO944513D0 (no) 1994-11-25
FI945562A0 (fi) 1994-11-25
CA2136669A1 (en) 1995-05-27
DK0655445T3 (da) 1998-03-23
ES2107157T3 (es) 1997-11-16
KR950014088A (ko) 1995-06-15
GR3025272T3 (en) 1998-02-27
PL305999A1 (en) 1995-05-29
IL111769A (en) 1999-04-11
AU679127B2 (en) 1997-06-19
EP0655445B1 (fr) 1997-08-27
EP0655445A1 (fr) 1995-05-31
DE69405198T2 (de) 1998-01-29

Similar Documents

Publication Publication Date Title
NO173139C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-aminopyrimidinonderivater
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
ZA897660B (en) Biologically active compounds
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
NO174711C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive pyrimidindionderivater
RU94022743A (ru) Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе
KR890001966A (ko) 함염성 아릴 유도체
RU94037246A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования разрушения хряща
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
RU94042230A (ru) Производные 1,3,4-оксадиазол-2-(3н)-она, их приготовление и применение в терапии
NO881835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
NO167737C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidazo(1,4)benzodiazepin-2-oner.
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
DK121789A (da) 4,5,6,7-tetrahydroisothiazole oe4,5-caapyridinderivater
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ES557597A0 (es) Procedimiento para preparar acidos hexenoicos
RU94045839A (ru) Производные 3-(фенилалкиламиноалкилокси)-5-фенилпиразола, а также способ и промежуточные вещества для их получения, лекарственное средство, содержащее эти соединения
AU2013888A (en) Uricosuric composition
HUT45062A (en) Process for producing 1-hydroxy-5-oxo-5h-pindo/3,2-a/ phenoxazine-3-carboxylic acid esters and pharmaceuticals comprising the same as active ingredient
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ES8504701A1 (es) Procedimiento para preparar derivados de 3-aril-3-pirrolina